Micro Dose Gets FDA Nod For Pediatric Imaging

EOS imaging received U.S. FDA clearance for Micro Dose, an option now available on EOS equipment that lowers dose of pediatric spine follow-up imaging exams, the company announced.

Micro Dose is designed for pediatric patients with orthopedic conditions that require frequent imaging exams for continuous monitoring of disease progression and treatment, the company said. Initial results presented at RSNA 1014 showed that Micro Dose generates dosage levels equivalent to a week of naturally-occurring background radiation in pediatric patients receiving 2D and 3D follow-up examinations, the company announced.

Micro Dose is in full accordance with the As Low As Reasonably Achievable (ALARA) principle, Marie Meynadier, CEO of EOS imaging, said in a release.